On March 8, 2017, MOU was signed between Asan Medical Center's new drug development bio-imaging center (C-BIND) and BioActs. Biosimilar analysis and active exchange of academic information will be carried out through friendly cooperation between the two institutions. We will look for products optimized for various fields of experiment and purpose of bio-imaging.